abstract |
Disclosed is a drug for preventing or treating a TGFβ-related disease by inhibiting TGFβ signaling. A TGFβ inhibitor comprising, as an active ingredient, a partial protein containing REIC / Dkk-3 protein or a Cys-rich domain thereof or a DNA encoding the same, and a preventive or therapeutic agent for a TGFβ related disease comprising the TGFβ inhibitor . [Selection figure] None |